IPO Watch
Rapid HIV & COVID-19 test maker Atomo Diagnostics is set to be the first IPO in 6 weeks
IPO Watch
IPO Watch: Market selloff weighs on ASX debutantes
IPO Watch
IPO Watch: It’s been an unpredictable ride for newbies so far in 2020
IPO Watch
IPO Watch: Another pot stock crops up on the ASX and fails to get investors high
IPO Watch
IPO Watch: Intelicare eyes ASX listing to drive growth for its AI-based aged care technology
IPO Watch
IPO Watch: Cashed-up Castile is already weighing up development options for Rover 1
IPO Watch
IPO Watch: Emerald Clinics is the latest pot stock to wilt on its ASX debut
IPO Watch
IPO Watch: It’s out with the old, in with the new as ARMnet eyes listing for ‘iPaas’ tech platform
IPO Watch
IPO Watch: Cobre makes an impression on ASX debut, gains 33pc
IPO Watch
IPO Watch: 2020 is off to a strong start as a number of mining explorers prepare to list
IPO Watch
IPO Watch: Aspiring Kiwi dairy play Happy Valley Nutrition skids on ASX debut
IPO Watch
IPO Watch: Noxopharm spin-off Nyrada gains 17.5pc on ASX debut
Featured IPO Watch Stocks
IPO Watch
Want to know which emerging companies are next to hit the boards? Our regular IPO watch list stories have you covered.
When it comes to an emerging company’s big debut, Stockhead is there to find out whether it flies or flops, with regular news updates and recaps of how the newest players are performing.
